| CAT No: | CL-TDMD-03 |
| CAS No: | NA |
| Mol.F: | C28H38N2O13 |
| Mol.Wt.: | 610.6 |
| Chemical Name: | 1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-3,6,9,12,15,18-hexaoxahenicosan-21-oic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to Thalidomide-O-PEG6-Acid is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Thalidomide-O-PEG6-Acid is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:1-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)-3,6,9,12,15,18-hexaoxahenicosan-21-oic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Thalidomide Molecular Formula: C28H38N2O13
Molecular Weight: 610.6
Storage: Store in a cool, dry place.
| Product Name: | Thalidomide-O-PEG6-Acid |
| CAS No: | |
| Mol.F.: | C28H38N2O13 |
| Mol.Wt.: | 610.6 |
Cat. No: CL-TDMD-01
CAS No: 50-35-1
Mol. F: C13H10N2O4
Mol. Wt: 258.2
Inv. Status: Custom Synthesis
Cat. No: CL-TDMD-02
CAS No: NA
Mol. F: C10H15NO5
Mol. Wt: 229.2
Inv. Status: Custom Synthesis
Cat. No: CL-TDMD-04
CAS No: NA
Mol. F: C41H67N5O12S
Mol. Wt: 854.1
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: